Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 1:18 AM
NCT ID:
NCT03449693
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients \> 9 years old
* Pediatric patients with solid tumors treated with cisplatin-based chemotherapy
* Signing of Informed Consent from the parents
* Signing of Informed Assent from the children
Non-inclusion Criteria:
* Patients whose parents do not sign the Informed Consent
* Patients with magnesium losing tubulopathy
* Patients with hypomagnesemia previous to the cisplatin-based chemotherapy
Exclusion Criteria:
\- Patients whose parents retire the Informed Consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
9 Years
Maximum Age:
18 Years
Study:
NCT03449693
Study Brief:
Protocol Section:
NCT03449693